Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Survey: Most physicians who treat STIs in their offices lack key injectable drugs

Key clinical point: Physicians who treat STIs in their offices should maintain stocks of the appropriate injectable drugs.

Major finding: Among physicians treating STIs in their offices, 77.9% did not have penicillin G benzathine available on- site, and 56.1% did not have ceftriaxone.

Study details: Survey results from the 2016 Physician Induction File of the National Ambulatory Medical Care Survey.

Disclosures: The authors are all employees of the CDC and did not provide other disclosures.


Pearson WS et al. Emerg Infect Dis. 2019. doi: 10.3201/eid2511.190764.